Literature DB >> 11472311

Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus.

R F Souza1, C P Morales, S J Spechler.   

Abstract

Oesophageal adenocarcinoma is one of the most deadly human malignancies. Gastro-oesophageal reflux disease (GERD) has been established as a strong risk factor for oesophageal adenocarcinoma, and more than 40% of adult Americans experience regular GERD symptoms. GERD can be complicated by oesophagitis, and by replacement of oesophageal squamous mucosa with metaplastic, intestinal-type epithelium (Barrett's oesophagus) that is predisposed to malignancy. Cancers in Barrett's oesophagus arise through a sequence of genetic alterations which endow unlimited proliferative capacity upon the cells by affecting components of the cell cycle clock apparatus-the pivotal molecular machinery in the cell nucleus that controls whether a cell will proliferate, differentiate, become quiescent or die. This report describes how the genetic abnormalities that have been recognized in Barrett's oesophagus might promote carcinogenesis through effects on the cell cycle clock machinery. The goal of this review is to provide the clinician with a useful conceptual basis for evaluating studies on the molecular mechanisms underlying the progression from metaplasia to carcinoma in Barrett's oesophagus.

Entities:  

Mesh:

Year:  2001        PMID: 11472311     DOI: 10.1046/j.1365-2036.2001.01046.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  14 in total

1.  Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S.

Authors:  Jie Hong; Murray Resnick; Jose Behar; Li Juan Wang; Jack Wands; Ronald A DeLellis; Rhonda F Souza; Stuart J Spechler; Weibiao Cao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-24       Impact factor: 4.052

2.  Role of NADPH oxidase NOX5-S, NF-κB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells.

Authors:  Jie Hong; Dan Li; Jack Wands; Rhonda Souza; Weibiao Cao
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-11       Impact factor: 4.249

3.  Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.

Authors:  Pierre Lao-Sirieix; Rebecca Brais; Laurence Lovat; Nicholas Coleman; Rebecca C Fitzgerald
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

4.  Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.

Authors:  R Langer; B H A Von Rahden; J Nahrig; C Von Weyhern; R Reiter; M Feith; H J Stein; J R Siewert; H Höfler; M Sarbia
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

5.  A relation between cell cycle and intestinal metaplasia in oesophageal biopsies using optical and digital microscopy.

Authors:  Miklós Máté; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2015-03-05       Impact factor: 3.201

6.  Esophageal adenocarcinoma arising from Barrett's dysplasia: a case report of double occurrence and prolonged survival after chemotherapy.

Authors:  Hemender S Vats; Tarit K Banerjee; Jeffrey Resnick; Qaseem Khan
Journal:  Clin Med Res       Date:  2006-09

7.  Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma.

Authors:  Jie Hong; Jose Behar; Jack Wands; Murray Resnick; Li Juan Wang; Ronald A DeLellis; David Lambeth; Rhonda F Souza; Stuart J Spechler; Weibiao Cao
Journal:  Gut       Date:  2009-11-18       Impact factor: 23.059

Review 8.  Esophageal adenocarcinoma arising in Barrett esophagus.

Authors:  Hui Ying Zhang; Stuart Jon Spechler; Rhonda F Souza
Journal:  Cancer Lett       Date:  2008-08-13       Impact factor: 8.679

9.  The molecular basis of carcinogenesis in Barrett's esophagus.

Authors:  Rhonda F Souza
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

10.  Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.

Authors:  Penelope A Bradbury; Rihong Zhai; Jessica Hopkins; Matthew H Kulke; Rebecca S Heist; Simron Singh; Wei Zhou; Clement Ma; Wei Xu; Kofi Asomaning; Monica Ter-Minassian; Zhaoxi Wang; Li Su; David C Christiani; Geoffrey Liu
Journal:  Carcinogenesis       Date:  2009-03-25       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.